NORTHERN TRUST CORP - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,755,126
-20.6%
412,444
-0.3%
0.00%0.0%
Q2 2023$3,470,742
+308.9%
413,676
+383.9%
0.00%
Q1 2023$848,876
+42.1%
85,486
-0.4%
0.00%
Q4 2022$597,245
+30.4%
85,811
-0.0%
0.00%
Q3 2022$458,000
+27.2%
85,821
-4.8%
0.00%
Q2 2022$360,000
-81.6%
90,152
-79.5%
0.00%
Q1 2022$1,953,000
+7.5%
439,453
-3.2%
0.00%
Q4 2021$1,816,000
-56.7%
454,115
-5.0%
0.00%
-100.0%
Q3 2021$4,198,000
-26.3%
478,058
-5.0%
0.00%0.0%
Q2 2021$5,699,000
+431.6%
503,064
+457.7%
0.00%
Q1 2021$1,072,000
+112.7%
90,202
+23.0%
0.00%
Q4 2020$504,000
-9.8%
73,364
-2.7%
0.00%
Q3 2020$559,000
+170.0%
75,424
+52.0%
0.00%
Q2 2020$207,000
-68.1%
49,622
-81.1%
0.00%
Q1 2020$649,000
-56.4%
262,816
+2.6%
0.00%
Q4 2019$1,489,000
+9.6%
256,276
-0.6%
0.00%
Q3 2019$1,359,000
-23.5%
257,862
-12.9%
0.00%
Q2 2019$1,777,000
-28.9%
296,129
+6.9%
0.00%
-100.0%
Q1 2019$2,501,000
+15.6%
276,926
+6.2%
0.00%0.0%
Q4 2018$2,164,000
-23.6%
260,761
+27.1%
0.00%0.0%
Q3 2018$2,831,000
+86.2%
205,082
+7.2%
0.00%
Q2 2018$1,520,000
+321.1%
191,275
+297.2%
0.00%
Q1 2018$361,000
+48.0%
48,151
+34.3%
0.00%
Q4 2017$244,000
+96.8%
35,861
+107.7%
0.00%
Q3 2017$124,000
+77.1%
17,267
+15.1%
0.00%
Q2 2017$70,000
-6.7%
14,9990.0%0.00%
Q1 2017$75,000
-2.6%
14,999
+4.7%
0.00%
Q4 2016$77,000
-23.0%
14,324
+11.5%
0.00%
Q3 2016$100,000
+42.9%
12,846
+3.9%
0.00%
Q2 2016$70,000
+37.3%
12,366
+0.7%
0.00%
Q1 2016$51,000
-38.6%
12,2860.0%0.00%
Q4 2015$83,000
+16.9%
12,2860.0%0.00%
Q3 2015$71,000
-17.4%
12,286
+10.6%
0.00%
Q2 2015$86,00011,1060.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders